Loop Recorder (ILR) Overview

An insertable cardiac monitor is a thumb-sized subcutaneous device with no therapy capability — its job is to record cardiac rhythm continuously, detect predefined arrhythmias, and transmit episodes for review. Battery life is roughly 3-5 years depending on activity.

How the system works

• Bipolar sensing between two electrodes on the device housing — no leads.
• Continuous loop recording: the device overwrites old data unless an algorithm-detected event or a patient-triggered marker preserves a segment.
• Algorithms detect bradycardia, asystole, tachycardia, AT/AF, and patient-activated events.
• Stored episodes transmit automatically (scheduled) and on-demand to the clinic via either a base station or a smartphone app.

Types / Variants

Medtronic LINQ II

• Insertion via a dedicated incision tool with the device delivered through a sub-Q channel.
• Remote monitoring through the MyCareLink Heart smartphone app or the CareLink base station for patients without smartphones.
• MRI 1.5T and 3T conditional.
• Programmable detection thresholds (AT/AF episode duration, brady cutoff, asystole pause length, tachycardia rate).
• Battery longevity quoted at up to 4.5 years.

Abbott Confirm Rx

• Pre-loaded delivery tool; sub-Q channel insertion similar workflow.
• Fully smartphone-driven remote monitoring via the myMerlinPulse app — Bluetooth pairing with the patient’s phone, no base station.
• MRI 1.5T and 3T conditional.
• Battery longevity historically around 2 years; current generations extend further.
• Programming via tablet at office visits.

Side-by-side

Indications & candidate selection

Strong indications:

• Unexplained syncope after a non-diagnostic initial workup (negative tilt, negative echo, non-diagnostic Holter / extended monitor).
• Cryptogenic stroke with no documented AF and a need for surveillance.
• Suspected paroxysmal AF where shorter monitors haven’t captured it.
• Recurrent palpitations without correlation on prior monitoring.
• Risk stratification in selected channelopathy or post-ablation populations.

Key programming considerations

• Brady / asystole: typical asystole cutoff 3-4.5 s; tune based on indication.
• Tachycardia: typical >=180 bpm with a minimum duration (e.g., 16 beats).
• AT/AF: minimum episode duration commonly set at 2-6 minutes — shorter durations explode the false-positive workload.
• Patient-triggered: ensure the patient knows how and when to mark events (app or hand-held activator).
• Remote schedule: monthly transmissions plus alert-triggered transmissions; weekly during active diagnostic workup.

What to know in the lab

• Insertion is a 5-minute sub-Q procedure under local anaesthesia.
• Standard site: left fourth intercostal space, parasternal, oriented at roughly 45 degrees to the sternum for best R-wave capture.
• Use the device-specific incision tool — depth control matters; too superficial risks erosion, too deep degrades amplitude.
• Confirm R-wave amplitude on the live screen before closure — target >=0.3 mV (LINQ II) or comparable on Confirm Rx.
• Pair the patient’s app or base station before they leave the room — pairing failure is the most common cause of missed transmissions in the first month.

Common issues & troubleshooting

• AF over-detection — review every episode’s EGM; PVC bigeminy and frequent PACs commonly fool the algorithm.
• Asystole over-call — undersensing of low-amplitude beats during sleep or specific postures; verify by EGM, consider repositioning if persistent.
• Tachycardia false positives — T-wave oversensing or myopotentials; reposition or adjust sensitivity at follow-up.
• Connectivity dropouts — base station moved away from bedside; app permissions / Bluetooth disabled. Check at every visit.
• Erosion / superficial migration — uncommon but more likely in thin patients with superficial placement; consider relocation if the device becomes visible.

Manufacturer reference

• Medtronic LINQ II
• Abbott Confirm Rx ICM